Access Bio, Inc. (KOSDAQ:950130)

Access Bio Revenue

Access Bio had revenue of 5.39B KRW in the quarter ending March 31, 2026, a decrease of -75.17%. This brings the company's revenue in the last twelve months to 14.94B, down -84.83% year-over-year. In the year 2025, Access Bio had annual revenue of 31.26B, down -72.21%.

• Revenue (ttm): 14.94B
• Revenue Growth: -84.83%
• P/S Ratio: 6.11
• Revenue / Employee: 147.91M
• Employees: 101
• Market Cap: 91.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	31.26B	-81.21B	-72.21%
Dec 31, 2024	112.46B	-236.18B	-67.74%
Dec 31, 2023	348.64B	-685.22B	-66.28%
Dec 31, 2022	1.03T	528.75B	104.68%
Dec 31, 2021	505.11B	383.31B	314.71%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error